First-in-human study of SAR445611 in healthy adult participants
This is a very early study looking at a new medicine called SAR445611. It's the first time this medicine is being given to people, specifically healthy adult volunteers. The main goal is to check how safe it is and how the body handles it. This kind of research is really important because it helps scientists understand if a new medicine has the potential to treat conditions where the body's immune system isn't working as it should. While this study is not for patients with actual diseases, the information gathered from healthy volunteers is a crucial first step in developing new treatments that could one day help many people.
At a glance
What is this study about?
Imagine your body's immune system as a fantastic army, protecting you from invaders like germs and viruses. Sometimes, this army can get a bit confused and start attacking healthy parts of your own body. This leads to what are called immune system diseases. Right now, scientists are always looking for better ways to help people whose immune systems are causing problems.
This particular study is a very early step in developing a new medicine, which has the code name SAR445611. It's the first time this medicine is being given to people, so it's a careful first look at how the medicine behaves in the human body. Because it's so new, the study is involving healthy adults, not people who are ill. This allows researchers to focus on how safe the medicine is and how the body processes it, without worrying about other health conditions.
The main purpose of this study is to gather important information about SAR445611. Things like, how much of the medicine stays in the body, how long it stays there, and if there are any immediate side effects. This knowledge is essential for deciding if the medicine should be tested further in people with immune system diseases. It's a foundational piece of the puzzle that could eventually lead to new treatments.
Key takeaways
- This is an early-stage study of a new medicine for immune system conditions.
- It's the first time this medicine is being given to healthy adult volunteers.
- The main goal is to check how safe the medicine is and how the body handles it.
- Participation involves health checks, receiving the medicine, and regular monitoring.
- Your involvement could help develop future treatments, but potential risks exist.
- You can withdraw from the study at any time.
Who may be eligible?
To join this study, you need to be a healthy adult aged 18 or older. There isn't an upper age limit, but you must be healthy enough to take part safely, as determined by the study doctors.
Both men and women are welcome to participate. The study team will carry out health checks to make sure joining is right for you. They will explain all the requirements and answer any questions you have.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you consider yourself to be in good general health?
- Are you willing to undergo medical check-ups and follow study instructions?
- Are you comfortable with the possibility of being given a new, untested medicine?
What does participation involve?
If you decide to take part, you would first have a full health check to make sure you are suitable. This would involve a review of your medical history, a physical exam, and some basic tests. You would then receive the study medicine, SAR445611. This study is likely to involve several visits to the clinic, and possibly an overnight stay or two, so doctors can carefully monitor how your body reacts to the medicine.
Throughout the study, you would have regular health checks, blood tests, and other assessments to track your well-being and how the medicine is working. The study team will tell you the exact schedule of visits and the total time commitment, which could range from a few weeks to a few months including follow-up checks after you've stopped taking the medicine.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is an 'immune system disease'?
An immune system disease is when your body's natural defences (immune system) mistakenly attack healthy parts of your own body, causing problems and symptoms.
Why is this study using healthy volunteers instead of people who are ill?
Because this is the very first time this medicine is being given to humans, it's safer to test it in healthy people first. This helps researchers understand its basic safety and how it works in the body without other health conditions making things complicated.
What does 'first-in-human' mean?
It means this is the initial study where a new medicine is given to people. Before this, it would have been tested in laboratories and possibly in animals.
Will I be paid to take part?
Study participation often involves compensation for your time and travel, but specific details would be provided by the study team if you express interest.
What happens after this study?
If SAR445611 is found to be safe and shows promise in this early stage, it might then be tested in future studies involving people with actual immune system diseases.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.